Lanean...

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice

Nitrogen-containing bisphosphonates are potent inhibitors of osteoclastic bone resorption. With their individually proven efficacy to significantly reduce the incidence of vertebral and/or non-vertebral fractures and with their overall beneficial safety profile, alendronate, ibandronate, risedronate...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bock, Oliver, Felsenberg, Dieter
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2008
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2546473/
https://ncbi.nlm.nih.gov/pubmed/18686751
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!